Trial intelligence / Profile preview

Pharmacokinetics of prophylactic antibiotics during cesarean section in pregnant women across BMI categories

NL-OMON52470Phase 4Recruiting

Sponsor
Erasmus MC
Start
Aug 2020
Countries
1
01

Overview

Phase 4, open-label trial in Infection and surgical site infection (SSI) (4 arms), sponsored by Erasmus MC. Primary endpoint: Maternal pharmacokinetics of standard postsurgical prophylactic antibiotic regimen. Started Aug 2020; status: recruiting.

02

Conditions

Infectionsurgical site infection (SSI)

Beyond the preview

Go deeper on NL-OMON52470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON52470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call